The role of active metabolites in drug toxicity
- PMID:7945999
- DOI: 10.2165/00002018-199411020-00006
The role of active metabolites in drug toxicity
Abstract
Adverse drug reactions can be caused by the parent drug or a metabolite of that drug. The metabolite may be stable or chemically reactive, the resultant toxicity being either a direct extension of the pharmacology of the drug, or unrelated to the known pharmacology of the drug and dependent on the chemical properties of the compound. Many different organ systems may be affected, and there are several mechanisms involved in determining organ-specific, and sometimes cell-selective, toxicity. An imbalance between bioactivation of a drug to a toxic metabolite and its detoxification is of prime importance in determining individual susceptibility. Such an imbalance may be genetically determined or acquired and, furthermore, may be systemic or tissue-specific. Prevention of metabolite-mediated toxicity is possible once the mechanism of toxicity has been elucidated.
Similar articles
- The role of reactive drug metabolites in immune-mediated adverse drug reactions.Hess DA, Rieder MJ.Hess DA, et al.Ann Pharmacother. 1997 Nov;31(11):1378-87. doi: 10.1177/106002809703101116.Ann Pharmacother. 1997.PMID:9391694Review.
- Detecting reactive drug metabolites for reducing the potential for drug toxicity.Grillo MP.Grillo MP.Expert Opin Drug Metab Toxicol. 2015;11(8):1281-302. doi: 10.1517/17425255.2015.1048222. Epub 2015 May 25.Expert Opin Drug Metab Toxicol. 2015.PMID:26005795Review.
- Extrahepatic targets and cellular reactivity of drug metabolites.Orhan H.Orhan H.Curr Med Chem. 2015;22(4):408-37. doi: 10.2174/0929867321666140826113716.Curr Med Chem. 2015.PMID:25174932Review.
- Genetically determined differences in drug metabolism as a risk factor in drug toxicity.Eichelbaum M, Kroemer HK, Mikus G.Eichelbaum M, et al.Toxicol Lett. 1992 Dec;64-65 Spec No:115-22. doi: 10.1016/0378-4274(92)90180-r.Toxicol Lett. 1992.PMID:1471165Review.
- Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.Thompson RA, Isin EM, Ogese MO, Mettetal JT, Williams DP.Thompson RA, et al.Chem Res Toxicol. 2016 Apr 18;29(4):505-33. doi: 10.1021/acs.chemrestox.5b00410. Epub 2016 Jan 6.Chem Res Toxicol. 2016.PMID:26735163Review.
Cited by
- A Text Mining Protocol for Extracting Drug-Drug Interaction and Adverse Drug Reactions Specific to Patient Population, Pharmacokinetics, Pharmacodynamics, and Disease.Shukkoor MSA, Baharuldin MTH, Raja K.Shukkoor MSA, et al.Methods Mol Biol. 2022;2496:259-282. doi: 10.1007/978-1-0716-2305-3_14.Methods Mol Biol. 2022.PMID:35713869
- Adverse drug reactions.Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK.Pirmohamed M, et al.BMJ. 1998 Apr 25;316(7140):1295-8. doi: 10.1136/bmj.316.7140.1295.BMJ. 1998.PMID:9554902Free PMC article.Review.No abstract available.
- Adverse drug reactions: back to the future.Pirmohamed M, Park BK.Pirmohamed M, et al.Br J Clin Pharmacol. 2003 May;55(5):486-92. doi: 10.1046/j.1365-2125.2003.01847.x.Br J Clin Pharmacol. 2003.PMID:12755814Free PMC article.Review.No abstract available.
- Description of an Innovative Pediatric Individualized Therapeutics Clinic: Working toward Precision Drug Therapy.Sandritter TL, Dinh JC, Wagner JA, Lowry JA.Sandritter TL, et al.Children (Basel). 2019 Feb 25;6(2):35. doi: 10.3390/children6020035.Children (Basel). 2019.PMID:30823616Free PMC article.
- What is drug safety?: celebrating 20 years of the Drug Safety journal.Edwards IR.Edwards IR.Drug Saf. 2006;29(6):461-5. doi: 10.2165/00002018-200629060-00001.Drug Saf. 2006.PMID:16752930No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical